Posted at 20:48h
in News to Know
When treated with a low-dose of hormones from a contraceptive device, women with migraine with aura and menstrual-related migraine experienced significant improvement in both disorders.
These results in a recent study bring potentially good news for many women, but the lead author of the study, Anne Calhoun, MD, of the University of North Carolina in Chapel Hill, tempered her enthusiasm.
“I first urge caution,” she told Reuters Health, stressing that the study was small—just 23 subjects—and intended to guide future research. “Good science requires larger and more rigorous trials before definitive conclusions can be gained.”